Novo Integrated Sciences, Inc. (NVOS) DCF Valuation

Novo Integrated Sciences, Inc. (NVOS) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Novo Integrated Sciences, Inc. (NVOS) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Discover the true value of Novo Integrated Sciences, Inc. (NVOS) with our professional-grade DCF Calculator! Adjust key assumptions, explore various scenarios, and evaluate how changes affect the valuation of Novo Integrated Sciences, Inc. (NVOS) – all within a single Excel template.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020		 AY2
2021		 AY3
2022		 AY4
2023		 AY5
2024		 FY1
2025		 FY2
2026		 FY3
2027		 FY4
2028		 FY5
2029
Revenue 7.9 9.3 11.7 12.6 13.3 15.2 17.4 19.9 22.7 26.0
Revenue Growth, % 0 18.38 26.14 7.11 5.75 14.34 14.34 14.34 14.34 14.34
EBITDA -2.8 -2.6 -22.5 -5.8 -10.1 -8.7 -9.9 -11.3 -13.0 -14.8
EBITDA, % -35.38 -27.75 -191.52 -46.52 -75.79 -57.09 -57.09 -57.09 -57.09 -57.09
Depreciation 2.0 2.4 3.0 2.3 .0 2.9 3.3 3.8 4.3 4.9
Depreciation, % 25.27 25.44 25.72 18.32 0 18.95 18.95 18.95 18.95 18.95
EBIT -4.8 -4.9 -25.5 -8.2 -10.1 -10.8 -12.3 -14.1 -16.1 -18.4
EBIT, % -60.65 -53.18 -217.24 -64.84 -75.79 -70.89 -70.89 -70.89 -70.89 -70.89
Total Cash 2.1 8.3 2.2 .4 .8 4.4 5.0 5.7 6.5 7.5
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 2.0 2.3 2.1 1.5 3.2
Account Receivables, % 25.89 24.53 17.91 11.67 23.71
Inventories .0 .3 .9 1.1 1.0 .8 1.0 1.1 1.2 1.4
Inventories, % 0.000012721729 3.65 7.49 8.81 7.53 5.49 5.49 5.49 5.49 5.49
Accounts Payable .9 1.4 1.8 3.5 3.2 2.9 3.3 3.8 4.3 4.9
Accounts Payable, % 11.24 15.58 15.34 27.95 24.34 18.89 18.89 18.89 18.89 18.89
Capital Expenditure .0 -.3 -.2 .0 .0 -.2 -.2 -.2 -.2 -.3
Capital Expenditure, % -0.15406 -2.75 -1.62 -0.39154 -0.37026 -1.06 -1.06 -1.06 -1.06 -1.06
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -4.8 -4.9 -25.3 -8.1 -10.1 -10.7 -12.3 -14.0 -16.1 -18.4
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -3.9 -2.8 -22.5 -3.7 -12.0 -8.2 -9.3 -10.7 -12.2 -14.0
WACC, % 4.62 4.62 4.6 4.61 4.63 4.62 4.62 4.62 4.62 4.62
PV UFCF
SUM PV UFCF -47.0
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -14
Terminal Value -544
Present Terminal Value -434
Enterprise Value -481
Net Debt 4
Equity Value -485
Diluted Shares Outstanding, MM 18
Equity Value Per Share -26.91

What You Will Get

  • Editable Forecast Inputs: Effortlessly adjust assumptions (growth %, margins, WACC) to explore various scenarios.
  • Real-World Data: Novo Integrated Sciences, Inc. (NVOS) financial data pre-loaded to facilitate your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value for you.
  • Customizable and Professional: A refined Excel model that caters to your valuation requirements.
  • Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.

Key Features

  • Comprehensive Financial Data: Novo Integrated Sciences' historical financial statements and pre-filled projections.
  • Customizable Parameters: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Real-Time Insights: Observe the intrinsic value of Novo Integrated Sciences recalculating instantly.
  • Intuitive Visual Displays: Dashboard charts illustrate valuation outcomes and essential metrics.
  • Designed for Precision: A professional-grade tool tailored for analysts, investors, and finance professionals.

How It Works

  • Download: Obtain the pre-prepared Excel file containing Novo Integrated Sciences, Inc.'s (NVOS) financial data.
  • Customize: Modify forecasts such as revenue growth, EBITDA %, and WACC to fit your analysis.
  • Update Automatically: Watch as intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Develop various projections and instantly evaluate different outcomes.
  • Make Decisions: Leverage the valuation results to inform your investment approach.

Why Choose Novo Integrated Sciences, Inc. (NVOS)?

  • Save Time: Skip the complexities of financial modeling – our tools are ready for immediate use.
  • Enhance Accuracy: Dependable data and methodologies minimize valuation errors.
  • Completely Customizable: Adjust the model to align with your specific assumptions and forecasts.
  • User-Friendly: Intuitive visuals and outputs simplify the analysis of results.
  • Endorsed by Professionals: Crafted for experts who prioritize both precision and ease of use.

Who Should Use Novo Integrated Sciences, Inc. (NVOS)?

  • Health Science Students: Explore innovative approaches to integrated health solutions and apply them in practical scenarios.
  • Researchers: Utilize advanced models and data in studies related to integrated health sciences.
  • Investors: Evaluate market trends and assess the potential of Novo Integrated Sciences, Inc. (NVOS) in your investment strategy.
  • Healthcare Analysts: Enhance your analysis with a customizable model tailored for integrated health companies.
  • Entrepreneurs: Understand how innovative health solutions are developed and marketed in the public sector.

What the Template Contains

  • Historical Data: Includes Novo Integrated Sciences' past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Novo Integrated Sciences' intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Novo Integrated Sciences' financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

Es wurden keine passenden Produkte gefunden.